Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy

Molecular Imaging

Volumn 1, Issue 1, 2002, Pages 43-55

  Rehemtulla, Alnawaz ^a   Hall, Daniel E ^a   Stegman, Lauren D ^a   Prasad, Uttara ^a   Chen, Grace ^a   Bhojani, Mahaveer Swaroop ^a   Chenevert, Thomas L ^a   Ross, Brian D ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bioluminescence imaging; Cancer gene therapy; Diffusion MRI; Glioma; Molecular imaging; Yeast cytosine deaminase

Indexed keywords

BIOLUMINESCENCE; BRAIN; GENES; MEDICAL IMAGING; TUMORS;

GENE EXPRESSION;

GENETIC ENGINEERING;

CYTOSINE DEAMINASE; DEAMINASE; HYBRID PROTEIN; LUCIFERASE;

ADENOVIRUS; ANIMAL; ARTICLE; BRAIN TUMOR; ENZYMOLOGY; FISCHER 344 RAT; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETICS; GLIOMA; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RAT; REPORTER GENE; SACCHAROMYCES CEREVISIAE;

ADENOVIRIDAE; ANIMALS; BRAIN NEOPLASMS; CYTOSINE DEAMINASE; GENE EXPRESSION; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GLIOMA; LUCIFERASES; MAGNETIC RESONANCE IMAGING; MALE; NUCLEOSIDE DEAMINASES; RATS; RATS, INBRED F344; RECOMBINANT FUSION PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 0002179495     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535002753395707     Document Type: Article

References (40)

1. [1] Stejskal E, Tanner J (1965). Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys. 42:288-292.
2. Rowley H, Grant P, Roberts, T (1999). Diffusion MR Imaging. Theory and applications. Neuroimaging Clin N Am. 9:343-361.
3. Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JS, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM (2000), Applications of magnetic resonance In model systems: Cancer therapeutics. Neoplasia. 2:153-166.
4. Ross BD, Chenevert TL, Kim B, Ben-Yoseph O (1994). Magnetic resonance imaging and spectroscopy: Application to experimental neuro-oncology, Q Magn Reson Biol Med. 1:89-106.
5. Zhao M, Pipe JG, Bonnett J, Evelhoch JL (1996). Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer. 73:61-64.
6. Chenevert TL, McKeever PE, Ross BD (1997). Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res. 3:1457-1466.
7. Ross BD, Ben-Yoseph O, Chenevert TL (1997). In vivo magnetic resonance imaging and spectroscopy: application to brain tumors. In: Magnetic Resonance Spectroscopy and imaging in Neurochemistry, Vol. 8. Bachelard H, Ed., Plenum, New York, pp. 145-178.
8. 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res. 58:3791-3799.
9. Poptani H, Puumalainen AM, Grohn OH, Loimas S, Kainulainen R, Yla-Herttuala S, Kauppinen RA (1998). Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther. 5:101-109.
10. Galons JP, Altbach MI, Paine-Murrieta G, Taylor CW, Gillies RJ (1999). Early increases in breast tumor xenograft water mobility In response to Paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia. 1:113-117.
11. Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:491-495.
12. Contag CH, Jenkins D, Contag PR, Negrin RS (2000). Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia. 2:41-52.
13. Harris JD, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR (1994). Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther. 1:170-175.
14. Bourke RS, West CR, Chheda G, Tower DB (1973). Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res. 33:1735-1746.
15. Block E, Bennett J (1974). Pharmacological studies with 5-fluorocytosine. Med Radiol (Mosk). 19:476-482.
16. Pu AT, Robertson JM, Lawrence TS (1995). Current status of radiation sensitization by fluoropyrimidines. Oncology (Huntingt). 9:707-714.
17. Penn RD, Kroin JS, Harris JE, Chiu KM, Braun DP (1983). Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Appl Neurophysiol. 46:240-244.
18. Gerosa MA, Dougherty DV, Wilson CB, Rosenblum ML (1983). Improved treatment of a brain-tumor model: Part 2. Sequential therapy with BCNU and 5-fluorouracil. J Neurosurg. 58:368-373.
19. Dong Y, Wen P, Manome Y, Parr M, Hirshowitz A, Chen L, Hirschowitz EA, Crystal R, Weichselbaum R, Kufe DW, Fine HA (1996). In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther. 7:713-720.
20. Xu LF, Ge K, Zheng ZC, Sun LY, Liu XY (1996). Experimental treatment of brain tumor cells using CD suicide gene. Shih Yen Sheng Wu Hsueh Pao. 29:385-393.
21. Kim JH, Kolozsvary A, Rogulski K, Khil MS, Brown SL, Freytag SO (1998). Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Cancer J Sci Am. 4:364-369.
22. Ge K, Xu L, Zheng Z, Xu D, Sun L, Liu X (1997). Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine. Int J Cancer. 71:675-679.
23. Wang ZH, Samuels S, Gama Sosa MA, Kolodny EH (1998). 5-Fluorocytosine-mediated apoptosis and DNA damage in glioma cells engineered to express cytosine deaminase and their enhancement with Interferon. J Neurooncol. 36:219-229.
24. Aghi M, Kramm CM, Chou TC, Breakefield XO, Chiocca EA (1998). Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst. 90:370-380.
25. Erbs P, Exinger F, Jund R (1997). Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans. Curr Genet. 31:1-6.
26. Hayden MS, Linsley PS, Wallace AR, Marquardt H, Kerr DE (1998). Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae. Protein Expression Purif. 12:173-184.
27. Kievit E, Bershad EM, Ng EY, Sethna P, Dev I, Lawrence TS, Rehemtulla A (1999). Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon carcinoma xenografts. Cancer Res. 59:1417-1421.
28. Ross BD, Zhao Y-J, Neal ER, Stegman LD, Ercolani M, Ben-Yoseph O, Chenevert TL (1998). Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study. Proc Natl Acad Sci USA. 95:7012-7017.
29. Stegman LD, Rehemtulla A, Hamstra DA, Rice DJ, Jonas SJ, Stout KL, Chenevert TL, Ross BD (2000). Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther. 7:1005-1010.
30. Burdette J, Elster A, Ricci P (1998). Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput-Assist Tomogr. 22:792-794.
31. Chenevert TL, Stegman LD, Taylor JMG, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD (2000). Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy In brain tumors. J Natl Cancer Inst. 92:2029-2036.
32. Cherry SR, Shao Y, Silverman RW, Meadors K, Siegel S, Chatziioannou A, Young JW, Jones WF, Moyers JC, Newport D, Boutefnouchet A, Farquhar TH, Andreaco M, Paulus MJ, Binkley DM, Nutt R, Phelps ME (1997). MicroPET: a high resolution PET scanner for imaging small animals. IEEE Trans Nucl Sci. 44:1161-1166.
33. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawerence TS, Blasberg RG, Tjuvajev JG, Ross BD (1999). Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts in vivo with magnetic resonance spectroscopy. Proc Natl Acad Sci USA. 96: 9821-9826.
34. Tjuvajev JG, Joshi A, Callegari J, Lindsley L, Joshi R, Balatoni J, Finn R, Larson SM, Sadelain M, Blasberg RG (1999). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia. 1:315-320.
35. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Gren LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA. 96:2333-2338.
36. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, Phelps ME, Larson SM, Balatoni J, Finn R, Sadelain M, Tjuvajev J, Blasberg R (2000). Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2:118-138.
37. Hogemann D, Josephson L, Weissleder R, Basllion JP (2000), Improvement of MRI probes to allow efficient detection of gene expression. Bioconjugate Chem. 11:941-946.
38. Bremer C, Tung CH, Weissleder R (2001). In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med. 7:743-748.
39. Bremer C, Weissleder R (2001). In vivo imaging of gene expression. Acad Radiol. 8:15-23.
40. Meyer CR, Boes JL, Kim B, Bland PH, Zasadny KR, Kison PV, Koral K, Frey KA, Wahl RL (1997). Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin plate spline warped geometric deformations. Med Image Analysis. 1:195-206.